We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stem Cells Help Repair Neurons After Stroke

By Biotechdaily staff writers
Posted on 27 May 2002
Stem cells leave the bone marrow in the first hours and days following a stroke and migrate to the injured regions of the brain where they help repair damaged tissue, according to a study by researchers at the Medical College of Georgia (MCG, Atlanta, USA).

The researchers used a mouse model in which the animal's marrow was replaced with transgenic mouse cells that make a jellyfish protein, which fluoresces green so they could trace the cells and the repair process that occurs after stroke. More...
They discovered that the bone marrow cells not only help repair damaged tissue but also become endothelial cells that form new blood vessels and what appear to be new neurons. Now, the next phase of research is to learn what summons the cells to the injury site. The researchers are looking at specific molecules up-regulated in inflammation that they suspect are also involved in homing. Another critical phase of the research is to find out which specific stem cells are summoned and which are needed for various kinds of repair.

To improve stroke recovery, the patient's own cells could be used, which would avoid the issue of compatibility and the ethical controversy surrounding embryonic stem cells. Enhancing normal repair might be able to preserve a region of the brain that would normally die but is an area that can be targeted to recover. The research has implications for all kinds of brain damage early and late in life, such as cerebral palsy and Parkinson's and Alzheimer's disease.

"If this works out, you will be able to give individuals shots following stroke to boost their bone marrow to proliferate these stem cells to do specific tasks and to target specific groups of these stem cells important to blood vessel repair and the genesis of new neurons,” said Dr. William Hill, neuroscientist in the MCG department of cellular biology and anatomy and second author on the study, published in the May 2002 issue of Stroke.


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Steam Sterilizer
Hi Vac II Line
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.